A CEO of a large pharmaceutical company would like to determineif he should be placing more money allotted in the budget next yearfor television advertising of a new drug marketed for controllingdiabetes. He wonders whether there is a strong relationship betweenthe amount of money spent on television advertising for this newdrug called DIB and the number of orders received. Themanufacturing process of this drug is very difficult and requiresstability so the CEO would prefer to generate a stable number oforders. The cost of advertising is always an importantconsideration in the phase I roll-out of a new drug. Data that havebeen collected over the past 20 months indicate the amount of moneyspent of television advertising and the number of ordersreceived.